VIRGINIA RETIREMENT SYSTEMS ET Al Lowers Stock Holdings in DaVita Inc. $DVA

VIRGINIA RETIREMENT SYSTEMS ET Al lowered its stake in DaVita Inc. (NYSE:DVA) by 88.8% during the 4th quarter, Holdings Channel reports. The firm owned 16,900 shares of the company’s stock after selling 134,507 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in DaVita were worth $1,920,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of DVA. Arrowstreet Capital Limited Partnership lifted its stake in DaVita by 109.7% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 553,809 shares of the company’s stock worth $73,585,000 after purchasing an additional 289,725 shares in the last quarter. Man Group plc lifted its stake in DaVita by 1,608.6% in the 2nd quarter. Man Group plc now owns 285,809 shares of the company’s stock worth $40,713,000 after purchasing an additional 269,081 shares in the last quarter. Neuberger Berman Group LLC lifted its stake in DaVita by 138.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 463,250 shares of the company’s stock worth $61,502,000 after purchasing an additional 269,015 shares in the last quarter. Voloridge Investment Management LLC lifted its stake in DaVita by 2,905.7% in the 3rd quarter. Voloridge Investment Management LLC now owns 228,221 shares of the company’s stock worth $30,324,000 after purchasing an additional 220,628 shares in the last quarter. Finally, Todd Asset Management LLC purchased a new stake in DaVita in the 3rd quarter worth $21,842,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. TD Cowen boosted their target price on shares of DaVita from $144.00 to $201.00 and gave the stock a “hold” rating in a report on Monday. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and boosted their target price for the stock from $126.00 to $220.00 in a report on Wednesday, May 6th. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Finally, Barclays boosted their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $199.17.

DaVita Trading Up 3.6%

Shares of NYSE:DVA opened at $199.43 on Friday. The company has a market capitalization of $12.80 billion, a price-to-earnings ratio of 18.50, a PEG ratio of 0.63 and a beta of 0.84. DaVita Inc. has a 12 month low of $101.00 and a 12 month high of $202.69. The firm’s 50-day moving average is $158.38 and its 200 day moving average is $135.58.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.33 by $0.54. The company had revenue of $3.42 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm’s revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.00 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts forecast that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.50% of the company’s stock.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.